GO:1902103 negative regulation of metaphase/anaphase transition of meiotic cell cycle: Meiotic Checkpoint Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902103 describes any process that stops, prevents or reduces the frequency, rate or extent of the metaphase/anaphase transition of the meiotic cell cycle, as defined by QuickGO.
• The metaphase/anaphase transition in meiosis is driven by chromosome segregation machinery that depends on the microtubule cytoskeleton and its regulation by exogenous cues in mammalian oocytes.
• SUMO-2/3 modification of topoisomerase II is a mitotic regulatory mechanism that illustrates how SUMOylation can control chromosome dynamics at the metaphase-to-anaphase transition.
• Negative regulation of this transition is essential for preventing premature chromosome segregation and aneuploidy during meiosis.
• Key experimental approaches include live-cell imaging of meiotic spindles, knockout and point-mutation models of checkpoint and cytoskeletal genes, and proteomic analysis of SUMOylated substrates.
• EDITGENE provides CRISPR knockout, point-mutation, knock-in, overexpression cell models and library screening to dissect the genetic control of meiotic metaphase/anaphase transition.
Description
The metaphase/anaphase transition of the meiotic cell cycle is the point at which homologous chromosomes or sister chromatids separate to opposite poles, a step that must be tightly controlled to ensure faithful chromosome segregation. GO:1902103, negative regulation of metaphase/anaphase transition of meiotic cell cycle, refers to any process that stops, prevents or reduces the frequency, rate or extent of this transition. In mammalian oocytes, meiotic maturation is regulated by an interplay between exogenous cues and the microtubule cytoskeleton, which governs spindle assembly and chromosome movement. Because errors at this transition lead to aneuploidy, understanding its negative regulation is central to reproductive biology and developmental genetics. The SUMO-2/3 pathway, which regulates topoisomerase II during mitosis, provides a paradigm for how post-translational modifications can modulate chromosome dynamics at the metaphase-to-anaphase transition. Researchers studying GO:1902103 therefore focus on the checkpoint and cytoskeletal mechanisms that delay or inhibit anaphase onset during meiosis.
negative regulation of metaphase/anaphase transition of meiotic cell cycle At A Glance
| GO ID | GO:1902103 |
|---|---|
| GO term | negative regulation of metaphase/anaphase transition of meiotic cell cycle |
| Ontology | biological_process |
| Synonym | down regulation of meiotic metaphase/anaphase transition; inhibition of metaphase/anaphase transition of meiotic cell cycle; negative regulation of meiotic metaphase/anaphase transition |
| Major function | Stops, prevents or reduces the frequency, rate or extent of the metaphase/anaphase transition during meiosis. |
| Biological context | Meiotic cell cycle, chromosome segregation, spindle checkpoint control. |
| Related processes | Regulation of meiotic maturation, microtubule cytoskeleton organization, SUMOylation of chromosomal proteins. |
| Experimental focus | Oocyte maturation, checkpoint kinases, cytoskeletal dynamics, post-translational modifications. |
What Is GO:1902103?
GO:1902103 is a biological process term defined by QuickGO as any process that stops, prevents or reduces the frequency, rate or extent of metaphase/anaphase transition of meiotic cell cycle. In other words, it encompasses molecular and cellular events that act as brakes on the meiotic metaphase-to-anaphase switch, ensuring that chromosome segregation occurs only when the spindle and chromosomes are properly prepared. This negative regulation can operate through checkpoint signaling, post-translational modification of chromosomal proteins, or modulation of the microtubule cytoskeleton that drives chromosome movement.
Why Is negative regulation of metaphase/anaphase transition of meiotic cell cycle Important in Cell Biology?
Negative regulation of the meiotic metaphase/anaphase transition is critical because premature or unscheduled chromosome segregation causes aneuploidy, a hallmark of infertility, miscarriage, and developmental disorders. In mammalian oocytes, the interplay between exogenous cues and the microtubule cytoskeleton controls the timing of meiotic maturation, and disruption of this regulation can lead to chromosome missegregation. Post-translational modifiers such as SUMO-2/3 regulate topoisomerase II during mitosis, highlighting how SUMOylation can influence chromosome dynamics at the metaphase-to-anaphase transition. Thus, understanding GO:1902103 provides mechanistic insight into reproductive health and the origins of chromosomal instability.
• Prevents premature chromosome segregation during meiosis, reducing aneuploidy risk.
• Controls the timing of oocyte maturation in response to exogenous cues.
• Involves post-translational regulation of chromosomal proteins such as topoisomerase II by SUMO-2/3.
• Impacts fertility and reproductive outcomes in mammals.
• Provides a model for understanding checkpoint control mechanisms conserved with mitosis.
• Offers targets for studying chromosomal instability in disease.
• Enables functional dissection of meiotic checkpoint genes via CRISPR models.
• Supports development of reproductive toxicology and screening assays.
What Happens During negative regulation of metaphase/anaphase transition of meiotic cell cycle?
Integration of exogenous cues and microtubule dynamics
In simple terms: The oocyte listens to signals from outside and inside to decide when to divide.
In mammalian oocytes, meiotic maturation is regulated by an interplay between exogenous cues and the microtubule cytoskeleton, which controls spindle assembly and the timing of the metaphase/anaphase transition. Negative regulation of this transition can occur when these cues delay or inhibit the onset of anaphase until the spindle is properly formed.
SUMOylation of chromosomal proteins
In simple terms: Adding SUMO tags to proteins can put the brakes on chromosome separation.
SUMO-2/3 regulates topoisomerase II during mitosis, demonstrating that SUMOylation of chromosomal proteins can modulate the metaphase-to-anaphase transition. By analogy, SUMO-2/3-dependent regulation of topoisomerase II may contribute to negative regulation of the meiotic metaphase/anaphase transition.
Checkpoint-mediated delay of anaphase
In simple terms: A surveillance system can pause the cell cycle if something is wrong.
Negative regulation of the metaphase/anaphase transition often involves checkpoint mechanisms that sense improper chromosome attachment or spindle defects. Although specific meiotic checkpoint components are still being defined, the principle that surveillance pathways delay anaphase is well established in cell cycle biology, and the microtubule cytoskeleton is a key target of such regulation in oocytes.
Post-translational control of chromosome segregation machinery
In simple terms: Chemical tags on proteins can change how chromosomes are separated.
Post-translational modifications, including SUMOylation, can alter the activity of enzymes such as topoisomerase II that are required for chromosome dynamics. Such modifications provide a reversible mechanism for negatively regulating the metaphase/anaphase transition during meiosis.
Key Genes Involved in GO:1902103 negative regulation of metaphase/anaphase transition of meiotic cell cycle
The following genes and proteins have been implicated in the regulation of meiotic maturation, microtubule cytoskeleton dynamics, and SUMO-dependent control of chromosome segregation, providing candidate regulators of GO:1902103.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TOP2A | Topoisomerase II, regulated by SUMO-2/3 during mitosis | Candidate for SUMO-dependent control of meiotic chromosome segregation |
| SUMO2 | SUMO-2/3 modification of topoisomerase II | Post-translational regulator of metaphase/anaphase transition |
| SUMO3 | SUMO-2/3 modification of topoisomerase II | Post-translational regulator of metaphase/anaphase transition |
| TUBB | Microtubule cytoskeleton component | Cytoskeletal target in oocyte maturation |
| TUBA1A | Microtubule cytoskeleton component | Cytoskeletal target in oocyte maturation |
| MAPK1 | Signaling kinase in oocyte maturation | Exogenous cue integration |
| MAPK3 | Signaling kinase in oocyte maturation | Exogenous cue integration |
| CDK1 | Cell cycle kinase driving metaphase/anaphase transition | Core cell cycle regulator |
| CCNB1 | Cyclin B1, partner of CDK1 | Meiotic maturation control |
| BUB1 | Spindle checkpoint kinase | Candidate negative regulator of anaphase onset |
| BUBR1 | Spindle checkpoint kinase | Candidate negative regulator of anaphase onset |
| MAD2L1 | Spindle checkpoint protein | Candidate negative regulator of anaphase onset |
| PLK1 | Polo-like kinase regulating mitosis | Candidate regulator of meiotic transition |
| AURKA | Aurora kinase A, spindle assembly | Candidate regulator of meiotic transition |
| AURKB | Aurora kinase B, chromosome segregation | Candidate regulator of meiotic transition |
| ESPL1 | Separase, cleaves cohesin at anaphase | Direct effector of metaphase/anaphase transition |
| REC8 | Meiotic cohesin subunit | Target of separase, meiotic-specific |
How Is negative regulation of metaphase/anaphase transition of meiotic cell cycle Regulated?
Regulation of the meiotic metaphase/anaphase transition involves integration of exogenous cues with the microtubule cytoskeleton in mammalian oocytes. Post-translational modification by SUMO-2/3 regulates topoisomerase II during mitosis, providing a mechanism by which SUMOylation can modulate chromosome dynamics at the metaphase-to-anaphase transition. These regulatory layers ensure that anaphase onset is delayed until chromosomes are properly aligned and the spindle is intact.
negative regulation of metaphase/anaphase transition of meiotic cell cycle and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TOP2A | Chromosomal instability, cancer | Knockout or point-mutation cell model |
| SUMO2 | Aneuploidy, cancer | Overexpression or knockout model |
| SUMO3 | Aneuploidy, cancer | Overexpression or knockout model |
| CDK1 | Cell cycle dysregulation | Point-mutation knock-in model |
| CCNB1 | Meiotic maturation defects | Knockout or tagged knock-in model |
Aneuploidy and reproductive disorders
Failure to properly regulate the meiotic metaphase/anaphase transition can lead to aneuploidy, which is associated with infertility, miscarriage, and developmental syndromes. The interplay between exogenous cues and the microtubule cytoskeleton in oocyte maturation is critical for preventing such errors.
Cancer and chromosomal instability
Defects in the regulation of chromosome segregation, including SUMO-2/3-dependent control of topoisomerase II, can contribute to chromosomal instability observed in cancer cells. Understanding meiotic-specific negative regulation may inform mechanisms of mitotic dysregulation in tumors.
From negative regulation of metaphase/anaphase transition of meiotic cell cycle-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene accelerate meiotic metaphase/anaphase transition? | CRISPR knockout cell model |
| Does a specific phosphorylation site control checkpoint function? | Point-mutation knock-in model |
| Where does a regulator localize during meiosis? | Tagged knock-in (e.g., GFP) model |
| Does overexpression of a SUMO ligase delay anaphase? | Overexpression cell model |
| Which genes modify the transition in a genome-wide screen? | CRISPR library screening |
| What pathways are enriched among regulators? | Bioinformatics analysis of screening data |
How to Study the negative regulation of metaphase/anaphase transition of meiotic cell cycle Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Timing of metaphase/anaphase transition | Oocyte maturation studies |
| Proteomics | SUMOylated protein identification | Post-translational regulation |
| CRISPR knockout screening | Gene requirement for transition timing | Discovery of negative regulators |
| CRISPR activation screening | Gene overexpression effects | Gain-of-function studies |
| RNA-seq | Transcriptional changes during meiosis | Pathway analysis |
| Western blot | Protein expression and modification | Validation of candidates |
| Immunofluorescence | Spindle and chromosome morphology | Checkpoint activation assessment |
Live-cell imaging of meiotic spindles
Live-cell imaging with fluorescently labeled tubulin and chromosomes allows direct observation of the metaphase/anaphase transition and its delay or inhibition in oocytes, building on the understanding that the microtubule cytoskeleton is central to meiotic maturation.
Proteomic analysis of SUMOylated proteins
Mass spectrometry-based proteomics can identify SUMO-2/3 substrates such as topoisomerase II, revealing post-translational mechanisms that may negatively regulate the metaphase/anaphase transition.
CRISPR-based functional screens
Genome-wide CRISPR knockout or activation screens can identify genes whose loss or overexpression alters the timing of the meiotic metaphase/anaphase transition, providing unbiased discovery of regulators.
Biochemical assays of chromosome segregation machinery
In vitro assays measuring topoisomerase II activity or cohesin cleavage can dissect the molecular effects of SUMOylation and other modifications on the metaphase/anaphase transition.
How CRISPR Can Be Used to Study GO:1902103 negative regulation of metaphase/anaphase transition of meiotic cell cycle
Knockout
CRISPR knockout of candidate genes such as TOP2A, SUMO2, or SUMO3 can test whether their loss accelerates the meiotic metaphase/anaphase transition, providing causal evidence for negative regulation.
Point Mutation
Point-mutation knock-in of specific phosphorylation or SUMOylation sites can dissect which residues are required for negative regulation of the transition, informed by known regulatory modifications.
Knock-in
Tagged knock-in of endogenous loci with fluorescent or affinity tags enables real-time tracking of proteins during meiotic maturation and chromosome segregation.
Overexpression
Overexpression of candidate negative regulators, such as SUMO-2/3 or checkpoint kinases, can test whether increased dosage delays or inhibits the metaphase/anaphase transition.
How EDITGENE Supports negative regulation of metaphase/anaphase transition of meiotic cell cycle Research
Researchers studying negative regulation of metaphase/anaphase transition of meiotic cell cycle-related genes often need to determine whether a candidate gene is causally involved in delaying or inhibiting anaphase onset. EDITGENE provides a comprehensive suite of CRISPR-based cell models and screening services to enable such functional studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of metaphase/anaphase transition of meiotic cell cycle research.
Frequently Asked Questions About negative regulation of metaphase/anaphase transition of meiotic cell cycle
What is GO:1902103?
GO:1902103 is a Gene Ontology biological process term defined as any process that stops, prevents or reduces the frequency, rate or extent of metaphase/anaphase transition of meiotic cell cycle.
What genes are involved in negative regulation of metaphase/anaphase transition of meiotic cell cycle?
Genes implicated include TOP2A, SUMO2, SUMO3, CDK1, CCNB1, and spindle checkpoint genes such as BUB1 and MAD2L1, based on their roles in chromosome segregation and post-translational regulation.
How is the meiotic metaphase/anaphase transition regulated?
It is regulated by an interplay between exogenous cues and the microtubule cytoskeleton in oocytes, as well as by post-translational modifications such as SUMOylation of topoisomerase II.
Why is negative regulation of the meiotic metaphase/anaphase transition important?
It prevents premature chromosome segregation and aneuploidy, which are associated with infertility, miscarriage, and developmental disorders.
What experimental models are used to study GO:1902103?
Common models include CRISPR knockout and knock-in cell lines, overexpression systems, live-cell imaging of oocytes, and proteomic analysis of SUMOylated proteins.
How does SUMOylation affect the metaphase/anaphase transition?
SUMO-2/3 regulates topoisomerase II during mitosis, suggesting that SUMOylation can modulate chromosome dynamics at the metaphase-to-anaphase transition.
What diseases are linked to defects in meiotic chromosome segregation?
Aneuploidy-related conditions such as infertility and miscarriage, as well as chromosomal instability in cancer, have been linked to dysregulation of chromosome segregation.
Can CRISPR screens identify regulators of the meiotic metaphase/anaphase transition?
Yes, genome-wide CRISPR knockout or activation screens can uncover genes whose loss or overexpression alters the timing of the transition.
What is the role of the microtubule cytoskeleton in meiotic maturation?
The microtubule cytoskeleton is central to spindle assembly and chromosome movement, and its interplay with exogenous cues controls meiotic maturation.
How can EDITGENE help study GO:1902103?
EDITGENE offers CRISPR knockout, point-mutation, knock-in, overexpression cell models, library screening, and bioinformatics services to dissect the genetic control of the meiotic metaphase/anaphase transition.
Conclusion
GO:1902103, negative regulation of metaphase/anaphase transition of meiotic cell cycle, represents a critical safeguard against premature chromosome segregation during meiosis. The process is governed by the integration of exogenous cues with microtubule cytoskeleton dynamics and by post-translational modifications such as SUMOylation of topoisomerase II. Understanding these mechanisms has direct implications for reproductive health and chromosomal stability. EDITGENE provides the CRISPR tools needed to functionally dissect the genes and pathways that control this transition.
References
- 1. Albertini DF. 1992. Regulation of meiotic maturation in the mammalian oocyte: interplay between exogenous cues and the microtubule cytoskeleton.. Bioessays 14(2):97-103 PMID: 1575717
- 2. Azuma Y et al.. 2003. SUMO-2/3 regulates topoisomerase II in mitosis.. J Cell Biol 163(3):477-87 PMID: 14597774
